Sources | Names Used |
---|---|
CTRPv2 | selumetinib:decitabine (4:1 mol/mol) |
PharmacoGx | selumetinib:decitabine (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZHX3 | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
mRNA | RNF11 | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-05 |
mRNA | ACOT11 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
mRNA | BBS9 | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
mRNA | ARCN1 | CTRPv2 | pan-cancer | AAC | -0.14 | 3e-05 |
mRNA | PPP2R5B | CTRPv2 | pan-cancer | AAC | -0.14 | 3e-05 |
mRNA | ASCL5 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
mRNA | SPRY2 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
mRNA | POLR1D | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
mRNA | MAP1B | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-05 |